Get Free Stock Tips by Ripples Financial Advisory- Or Call on 9644405056
Shares of Lupin tumbled over 6 per cent on the Bombay stock Exchange as investors resorted to profit booking after rally in the last few sessions. Earlier on Thursday, the drug maker said that it has launched the generic Wellbutrin XL tablets in the United States after receiving an approval from the United States Food and Drug Administration (FDA) earlier.
Reacting to the news, shares of the company declined as much as 6.31 per cent to hit an intra-day low of Rs 1108.30 apiece on the Bombay Stock Exchange.
Get Free Stock Tips by Ripples Financial Advisory- Or Call on 9644405056
No comments:
Post a Comment